Alexandre Karras
Délégation Paris 5(FR)Inserm(FR)Université Paris-Est Créteil(FR)Université Paris Cité(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Center for Infection and Immunity of Lille(FR)Hôpital Européen Georges-Pompidou(FR)Centre Hospitalier Universitaire de Nîmes(FR)Hôpital Européen(FR)Paris Cardiovascular Research Center(FR)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Vasculitis and related conditions, Systemic Lupus Erythematosus Research, Amyloidosis: Diagnosis, Treatment, Outcomes, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies(2012)558 cited
- → Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus(2003)363 cited
- → Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)(2018)327 cited
- → INF2Mutations in Charcot–Marie–Tooth Disease with Glomerulopathy(2011)282 cited
- → Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C–related mixed cryoglobulinemia(2010)260 cited
- → Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis